Himension Capital (Singapore) Pte. Ltd. Intellia Therapeutics, Inc. Transaction History

Himension Capital (Singapore) Pte. Ltd.

$1.28 Billion
Q3 2024

A detailed history of Himension Capital (Singapore) Pte. Ltd. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Himension Capital (Singapore) Pte. Ltd. holds 1,075,711 shares of NTLA stock, worth $15 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares

1,075,711

Previous 1,029,982 4.44%

Holding current value

$15 Million

Previous $23.1 Million 4.1%

% of portfolio

1.73%

Previous 1.64%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$19.72 - $27.36 $901,775 - $1.25 Million	45,729 Added 4.44%	1,075,711 $22.1 Million
Q2 2024 Aug 13, 2024	SELL	$20.02 - $27.22 $12,792 - $17,393	-639 Reduced 0.06%	1,029,982 $23.1 Million
Q4 2023 Feb 13, 2024	SELL	$23.16 - $32.34 $2.65 Million - $3.7 Million	-114,470 Reduced 10.0%	1,030,621 $31.4 Million
Q4 2022 Feb 13, 2023	SELL	$33.21 - $62.69 $1.53 Million - $2.89 Million	-46,102 Reduced 3.87%	1,145,091 $40 Million
Q3 2022 Nov 09, 2022	SELL	$53.92 - $71.7 $1.36 Million - $1.8 Million	-25,147 Reduced 2.07%	1,191,193 $66.7 Million
Q2 2022 Aug 11, 2022	BUY	$38.49 - $76.21 $18.2 Million - $36 Million	472,180 Added 63.45%	1,216,340 $63 Million
Q1 2022 May 13, 2022	BUY	$58.27 - $118.99 $8.97 Million - $18.3 Million	153,920 Added 26.08%	744,160 $54.1 Million
Q4 2021 Feb 11, 2022	BUY	$100.76 - $138.36 $17.1 Million - $23.4 Million	169,381 Added 40.25%	590,240 $69.8 Million
Q3 2021 Nov 10, 2021	BUY	$132.37 - $176.78 $16 Million - $21.3 Million	120,532 Added 40.13%	420,859 $56.5 Million
Q2 2021 Aug 03, 2021	BUY	$60.88 - $161.91 $16.9 Million - $44.9 Million	277,207 Added 1198.99%	300,327 $48.6 Million
Q1 2021 May 07, 2021	BUY	$46.59 - $83.68 $1.08 Million - $1.93 Million	23,120 New	23,120 $1.86 Million

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.06B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Himension Capital (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Himension Capital (Singapore) Pte. Ltd. with notifications on news.

Account

Himension Capital (Singapore) Pte. Ltd. Intellia Therapeutics, Inc. Transaction History